| Half-life | 16 hours |
| Clearance Route | hepatic |
| Active Metabolites | yes |
| Notes | Long duration; minimal electrolyte disturbance compared to HCTZ. |
Severity: Moderate
Adverse Effects:
Hyponatremia, hypokalemia, dizziness
Contraindications:
Severe renal impairment, sulfonamide allergy
Precautions:
Monitor Na⁺/K⁺ periodically; caution in elderly